发明名称 |
Methods and compositions for targeting an activated vitronectin receptor with a ligand comprising adenovirus-2 penton base or fragment thereof |
摘要 |
Disclosed are ligands that can selectively bind to activated alpha v beta 3 integrin. A monovalent ligand- mimetic (WOW-1 Fab) which includes a single alpha v integrin-binding domain from multivalent adenovirus penton base is provided. Further disclosed are particular compositions of activated alpha v beta 3-specific ligands, such as an antibody which immunoreacts preferentially with activated alpha v beta 3 integrin. Also described are methods using an activated alpha v beta 3-specific ligand for diagnostic detection of activated alpha v beta 3 integrin in tissues and for the targeted delivery of therapeutic agents to tissues containing activated alpha v beta 3 integrin.
|
申请公布号 |
NZ511937(A) |
申请公布日期 |
2004.02.27 |
申请号 |
NZ19990511937 |
申请日期 |
1999.12.03 |
申请人 |
NOVARTIS AG;THE SCRIPPS RESEARCH INSTITUTE |
发明人 |
SHATTIL, SANFORD JACK;NEMEROW, GLEN ROBERT;STUPACK,DWAYNE GARRY;PAMPORI, NISAR AHMAD |
分类号 |
G01N33/566;A61K31/711;A61K35/76;A61K38/00;A61K39/395;A61K45/00;A61K48/00;A61P9/00;A61P27/00;A61P29/00;A61P35/00;C07K14/78;C07K16/28;C12N15/09;G01N33/53;G01N33/68;(IPC1-7):G01N33/53 |
主分类号 |
G01N33/566 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|